1. Destructive or harmful to schistosomes.
2. An agent capable of affecting the viability of schistosomes.
Farlex Partner Medical Dictionary © Farlex 2012
References in periodicals archive ?
Certain chemical constituents isolated from Pulsatilla species have been reported as antischistosomal agent [10], antibacterial agent [11], and for the treatment of hepatitis B virus infection and hepatoma [12].
Even though primaquine was provided to a minority of patients in this cohort, it should be provided to all eligible patients with persistent splenomegaly, and repeated antischistosomal therapy should be provided to patients with evidence of current or recent schistosomiasis.
The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt.
Focusing first on the methanol leaf extract for dose-response assays, the acetone fraction was potently antischistosomal with phenotypic alterations (degeneration and/or death, i.e., severity scores of 4) noted at both 24 and 48 h and at all dilutions (except 0.3125 [micro]g/ml at 24 h; Figure 1(a); see also Figure 3(b) for a photo of the affected somules).
In Egypt, the main routes of HCV transmission have included the mass parenteral antischistosomal treatment from the 1950s to the 1980s, shared and reused needles, inadequate sterilization during dialysis, surgery, and dental care, and unsafe blood transfusion.
A safe, effective, herbal antischistosomal therapy derived from myrrh.
Antischistosomal and hepatoprotective activity of Morus alba leaves extract.
sativa oil and garlic extract were used to see if there are any antischistosomal and antioxidant activity on normal and Sch.
Abu El Einin, "Molluscicidal and antischistosomal activities of methanol extracts and isolated compounds from Eucalyptus globulus and Melaleuca styphelioides," Pharmaceutical Biology, vol.
Another study from Cote d'Ivoire reports antischistosomal activity of hydroethanol extract of M.
The tegument is extremely important to the infection success and survival in the host, and it has been a major target for the development of antischistosomal drugs [28], since most of the currently used drugs against schistosomes, such as PZQ [41], mefloquine [42], and artemether [43], act by damaging the schistosome tegument.
Specific blood testing for schistosomal antibodies revealed an antischistosomal immunoglobulin G antibody level of 1.76 (normal 0-1.00).